The DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index.
Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy
Abstract
Autophagy is fundamental to the maintenance of intracellular homeostasis in virtually all human cells. Accordingly, defective autophagy predisposes healthy cells to undergoing malignant transformation. By contrast, malignant cells are able to harness autophagy to thrive, despite adverse microenvironmental conditions, and to resist therapeutic challenges. Thus, inhibition of autophagy has been proposed as a strategy to kill cancer cells or sensitize them to therapy; however, autophagy is also critical for optimal immune function, and mediates cell-extrinsic homeostatic effects owing to its central role in danger signalling by neoplastic cells responding to immunogenic chemotherapy and/or radiation therapy. In this Perspective, we discuss accumulating preclinical and clinical evidence in support of the all-too-often dismissed possibility that activating autophagy might be a relevant clinical objective that enables an increase in the effectiveness of immunogenic chemotherapy and/or radiation therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ICD can be initiated by a relatively restricted set of stimuli, including viral infection, some FDA-approved chemotherapeutics (e.g., anthracyclines, bortezomib), specific forms of radiation therapy, and hypericin-based photodynamic therapy [854–861].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [856]
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, R. C., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,214
Autophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,444
Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy
Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X. H., Mizushima, N., Packer, M., Schneider, M. D., & Levine, B. (2005) · Cell · doi:10.1016/j.cell.2005.07.002 · Cited by 3,536
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Self-citationThe role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865
Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
Sharma, P., & Allison, J. P. (2015) · Cell · doi:10.1016/j.cell.2015.03.030 · Cited by 2,345
Flagged first, then by citations
1 of the 126 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 314
Wu, J., Wang, J., Su, Q., Ding, W., Li, T., Yu, J., & Cao, B. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s157129 · Cited by 52
An emerging role for nanomaterials in increasing immunogenicity of cancer cell death
Mishchenko, T. A., Mitroshina, Е. V., Balalaeva, I. V., Krysko, O., Vedunova, M. V., & Krysko, D. V. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.11.004 · Cited by 53
The Multifunctional Protein p62 and Its Mechanistic Roles in Cancers
Ning, S., & Wang, L. (2018) · Current Cancer Drug Targets · doi:10.2174/1568009618666181016164920 · Cited by 55
Cucurbitacin I induces pro‐death autophagy in A549 cells via the ERK‐mTOR‐STAT3 signaling pathway
Ni, Y., Wu, S., Wang, X., Zhu, G., Chen, X., Ding, Y., & Jiang, W. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26808 · Cited by 50
Autophagy dysfunctions associated with cancer cells and their therapeutic implications
Udriştioiu, A., & Nica-Badea, D. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108892 · Cited by 53
Ma, W., Zhou, Y., Liu, M., Qin, Q., & Cui, Y. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01825-y · Cited by 48
Wang, L., Guan, R., Xie, L., Liao, X., Xiong, K., Rees, T. W., Chen, Y., Ji, L., & Chao, H. (2020) · Angewandte Chemie · doi:10.1002/ange.202013987 · Cited by 49
Shi, X., Wang, L., Li, X., Bai, J., Li, J., Li, S., Wang, Z., & Zhou, M.-R. (2017) · Oncotarget · doi:10.18632/oncotarget.17520 · Cited by 45
Wang, C., Peng, R., Zeng, M., Zhang, Z., Liu, S., Jiang, D., Lu, Y., & Zou, F. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03265-4 · Cited by 48
Involvement of autophagy in NK cell development and function
López‐Soto, A., Pedro, J. M. B., Kroemer, G., Galluzzi, L., & Gonzalez, S. R. (2017) · Autophagy · doi:10.1080/15548627.2016.1274486 · Cited by 46
Self-citationIs Autophagy Involved in the Diverse Effects of Antidepressants?
Rein, T. (2019) · Cells · doi:10.3390/cells8010044 · Cited by 45
Neddylation, a novel paradigm in liver cancer
Delgado, T. C., Barbier‐Torres, L., Zubiete‐Franco, I., Lopitz‐Otsoa, F., Varela‐Rey, M., Fernández‐Ramos, D., & Martínez‐Chantar, M. L. (2018) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2018.06.05 · Cited by 45
Wang, S., Xu, X., Hu, Y., Lei, T., & Liu, T. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01460 · Cited by 44
Dong, J., Wang, B., Xiao, Y., Liu, J., Wang, Q., Xiao, H., Jin, Y., Liu, Z., Chen, Z., Li, Y., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113846 · Cited by 43
Small-molecule drug repurposing to target DNA damage repair and response pathways
Brinkman, J. A., Liu, Y., & Kron, S. J. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.02.013 · Cited by 41
MCOLN1/TRPML1 in the lysosome: a promising target for autophagy modulation in diverse diseases
Qi, J., Li, Q., Xin, T., Lu, Q., Lin, J., Zhang, Y., Luo, H., Zhang, F., Xing, Y., Wang, W., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2333715 · Cited by 46
Que, T., Ren, B., Fan, Y., Liu, T., Hou, T., Dan, W., Liu, B., Wei, Y., Lei, Y., Zeng, J., et al. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110043 · Cited by 39
Autophagy Governs Protumorigenic Effects of Mitotic Slippage–induced Senescence
Jakhar, R., Luijten, M., Wong, A. X. F., Cheng, B., Guo, K., Neo, S. P., Au, B. V., Kulkarni, M., Lim, K. J., Maimaiti, J., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0024 · Cited by 39
Monitoring autophagy in cancer: From bench to bedside
Long, M., & McWilliams, T. G. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.016 · Cited by 30
Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications
Cabo, M., Offringa, R., Zitvogel, L., Kroemer, G., Muntasell, A., & Galluzzi, L. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1371896 · Cited by 37
Self-citationColorectal cancer, radiotherapy and gut microbiota
Zhang, S., Wang, Q., Zhou, C., Chen, K., Chang, H., Xiao, W., & Gao, Y. (2019) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2019.01.16 · Cited by 36
Mechanisms of immunogenic cell death and immune checkpoint blockade therapy
Lin, R. A., Lin, J. K., & Lin, S. (2021) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12375 · Cited by 38
Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group
Elsayad, K., Guenova, E., Assaf, C., Nicolay, J. P., Trautinger, F., Stadler, R., Waldstein, C., Boterberg, T., Meijnders, P. J., Kirova, Y., et al. (2024) · European Journal of Cancer · doi:10.1016/j.ejca.2024.115064 · Cited by 39
The SAR and action mechanisms of autophagy inhibitors that eliminate drug resistance
Ye, W., Fan, C., Fu, K., Wang, X., Lin, J., Nian, S., Liu, C., & Zhou, W. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114846 · Cited by 37
Wu, Y.-H., Hong, C.-W., Wang, Y., Huang, W., Yeh, Y.-L., Wang, B.-J., Wang, Y., & Chiu, H. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.023 · Cited by 34
Inhibition of autophagy initiation potentiates chemosensitivity in mesothelioma
Follo, C., Cheng, Y., Richards, W. G., Bueno, R., & Broaddus, V. C. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22757 · Cited by 35
Activated kinase screening identifies the IKBKE oncogene as a positive regulator of autophagy
Leonardi, M., Perna, E., Tronnolone, S., Colecchia, D., & Chiariello, M. (2018) · Autophagy · doi:10.1080/15548627.2018.1517855 · Cited by 35
Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy
Castoldi, F., Vacchelli, E., Zitvogel, L., Maiuri, M. C., Pietrocola, F., & Kroemer, G. (2019) · OncoImmunology · doi:10.1080/2162402x.2018.1498285 · Cited by 33
Self-citationEffects of microplastics on chemo-resistance and tumorigenesis of colorectal cancer
Pan, W., Han, Y., Zhang, M., Zhu, K., Yang, Z., Qiu, M., Guo, Y., Dong, Z., Hao, J., Zhang, X., et al. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02085-1 · Cited by 33
Potential diagnostic and therapeutic value of circular RNAs in cardiovascular diseases
Sun, J., Shi, Y., Cai, X., & Liu, J. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109604 · Cited by 33
Photoactivatable nanogenerators of reactive species for cancer therapy
Zheng, X., Jin, Y., Liu, X., Liu, T., Wang, W., & Yu, H. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.04.030 · Cited by 32
Therapy-Induced Tumor Cell Death: Friend or Foe of Immunotherapy?
van Schaik, T., Chen, K., & Shah, K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.678562 · Cited by 37
Dumas, J., Brisson, L., Chevalier, S., Mahéo, K., Fromont, G., Moussata, D., Besson, P., & Roger, S. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.004 · Cited by 33
Monitoring autophagy in live cells with a fluorescent light-up probe for G-quadruplex structures
Chen, H., Sun, H., Zhang, S., Yan, W., Li, Q., Guan, A., Xiang, J., Liu, M., & Tang, Y. (2019) · Chemical Communications · doi:10.1039/c9cc01263j · Cited by 31
Stimulating TRPM7 suppresses cancer cell proliferation and metastasis by inhibiting autophagy
Xing, Y., Wei, X., Wang, M., Liu, Y., Sui, Z., Wang, X., Zhang, Y., Fei, Y.-H., Jiang, Y., Chen, L., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.10.043 · Cited by 33
Involvement of circRNAs in the Development of Heart Failure
Sygitowicz, G., & Sitkiewicz, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214129 · Cited by 32
Recent advances of tanshinone in regulating autophagy for medicinal research
Wu, S., Zhao, K., Wang, J., Liu, N., Nie, K., Qi, L., & Xia, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1059360 · Cited by 32
Nti, A. A., Serrano, L. W., Sandhu, H. S., Uyhazi, K. E., Edelstein, I. D., Zhou, E. J., Bowman, S., Song, D., Gangadhar, T. C., Schuchter, L. M., et al. (2019) · Retina · doi:10.1097/iae.0000000000002027 · Cited by 31
The relationship between autophagy and PD-L1 and their role in antitumor therapy
Cui, Y., Shi, J., Cui, Y., Zhu, Z., & Zhu, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1093558 · Cited by 32
Lin, C., Tsao, Y., & Shu, C. (2021) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12361 · Cited by 31
Wu, Y.-H., Chen, R.-J., Chiu, H., Yang, L., Wang, Y., Chen, Y., Yeh, Y.-L., Liao, M., & Wang, Y. (2022) · Theranostics · doi:10.7150/thno.77233 · Cited by 32
Sequestosome 1/p62-related pathways as therapeutic targets in hepatocellular carcinoma
Denk, H., Stumptner, C., Abuja, P. M., & Zatloukal, K. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1601703 · Cited by 32
Trial watch: DNA-based vaccines for oncological indications
Pierini, S., Perales-Linares, R. F., Uribe‐Herranz, M., Pol, J. G., Zitvogel, L., Kroemer, G., Facciabene, A., & Galluzzi, L. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1398878 · Cited by 29
Self-citationThe DNA damage response in immunotherapy and radiation
Samstein, R. M., & Riaz, N. (2018) · Advances in Radiation Oncology · doi:10.1016/j.adro.2018.08.017 · Cited by 30
Tsai, C., Lin, T., Huang, S., Hsu, J., Yeh, C., Chen, T., Chiu, C., Chen, J., & Yeh, T. (2020) · The Oncologist · doi:10.1634/theoncologist.2019-0419 · Cited by 30
Sun, M.-H., Chen, X., Han, M. H., Yang, Y., Gao, X., Ma, X., Huang, Y., Li, X., Gai, M., Liu, F., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.008 · Cited by 28
Hu, M., Yu, Z., Mei, P., Li, J., Luo, D., Zhang, H., Zhou, M., Liang, F., & Chen, R. (2020) · Aging · doi:10.18632/aging.102606 · Cited by 28
Nan, Z., Dou, Y., Chen, A., Wang, K., Sun, J., Meng, Z., Neckenig, M. R., Ai, D., Liu, S., Dong, Z., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1100417 · Cited by 29
Tran, T.-H., Kao, M., Liu, H., Hong, Y., Su, Y., & Huang, C. F. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01190-5 · Cited by 28
Monitoring autophagic flux using p62/SQSTM1 based luciferase reporters in glioma cells
Zhang, M., Ting, Y., Mingtao, G., Tang, X., Dong, Y., Chen-guang, Z., & Ding, W. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.12.027 · Cited by 28
Cheng, X., Xia, T., Sun, X., Liang, G., Liu, X., & Liang, G. (2023) · ACS Central Science · doi:10.1021/acscentsci.3c00696 · Cited by 27
Li, Y., Yang, X., Yao, P., Shen, W., Wu, Y., Ye, Z., Zhao, K., Chen, H., Cao, J., & Xing, C. (2019) · PubMed · Cited by 28
Wang, J., Zhou, X., Wang, H., Xiao, Q., Ding, K., Dong, X., Xu, S., Shen, B., Sun, J., Zhou, Z., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120156 · Cited by 27
Wang, S., Tang, S., Chen, X., Li, X., Jiang, S., Li, H., Jia, P.-H., Song, M., Di, P., & Li, W. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109233 · Cited by 27
PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesis
Linares, J. F., Zhang, X., Martínez-Ordóñez, A., Durán, Á., Kinoshita, H., Kasashima, H., Nakanishi, N., Nakanishi, Y., Carelli, R., Cappelli, L. V., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.039 · Cited by 28
Li, R., Li, H., Lan, J., Yang, D., Lin, X., Xu, H., Han, B., Yang, M., Su, B., Liu, F., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154084 · Cited by 27
Immunosuppressive Cell Death in Cancer
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.48 · Cited by 26
Self-citationSelf‐Adjusting Engineered Probiotic for Targeted Tumor Colonization and Local Therapeutics Delivery
Zou, Z., Wang, X., Shi, X., Sun, S., Mi, J., Zhang, X. P., Yin, B., Zhou, Y. Q., & Ye, B. (2025) · Advanced Science · doi:10.1002/advs.202406486 · Cited by 28
Zhong, Y., Huang, G. M., Zhao, S., Chung, L., Zhang, H., Zheng, J., Yan, Y., Ni, W., & He, J. H. (2024) · Advanced Science · doi:10.1002/advs.202309068 · Cited by 25
Biomimetic Active Materials Guided Immunogenic Cell Death for Enhanced Cancer Immunotherapy
Huang, G., Liu, L., Pan, H., & Cai, L. (2022) · Small Methods · doi:10.1002/smtd.202201412 · Cited by 25
Targeting autophagy in thyroid cancers
Wei, W., Hardin, H. A., & Luo, Q. (2019) · Endocrine Related Cancer · doi:10.1530/erc-18-0502 · Cited by 25
Yang, Z., Pu, M., Dong, X., Ji, F., Veeraraghavan, V. P., & Yang, H. (2020) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2020.03.028 · Cited by 24
Sun, C., Cao, D., Ren, Q., Zhang, S., Zhou, N., Mai, S., Feng, B. C., & Wang, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.684243 · Cited by 24
Jiang, W., Wei, L., Chen, B., Luo, X., Xu, P., Cai, J., & Hu, Y. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01322-y · Cited by 24
Cheng, X., Xia, T., Zhan, W., Xu, H., Jiang, J., Liu, X., Sun, X., Wu, F., & Liang, G. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201916 · Cited by 24
Li, F., Zhou, X., Chen, M., & Fan, W. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104491 · Cited by 23
Graphene-Induced Hyperthermia (GIHT) Combined With Radiotherapy Fosters Immunogenic Cell Death
Podolska, M. J., Shan, X., Janko, C., Boukherroub, R., Gaipl, U. S., Szunerits, S., Frey, B., & Munoz, L. E. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.664615 · Cited by 23
Lam, B. K., Kung, Y. J., Lin, J. C., Tseng, S.-H., Tu, H.-F., Huang, C. Y. ‐., Lee, B., Velarde, E., Tsai, Y. C., Villasmil, R., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci171621 · Cited by 23
Fan, M., Gao, J., Zhou, L., Xue, W., Wang, Y., Chen, J., Li, W., Yu, Y., Liu, B., Shen, Y., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.05.009 · Cited by 22
Liu, X., Chen, Y., Fu, Y., Jiang, D., Gao, F., Tang, Z., Bian, X., Wu, S., Yu, Y., Wang, X., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c01446 · Cited by 22
Zhu, L., Zhu, Y., Li, F., Meng, Y. G., Wang, H., Xu, W., Luo, J., Wang, X., Feng, L., & Jin, H. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1337 · Cited by 22
Inflachromene inhibits autophagy through modulation of Beclin 1 activity
Kim, Y. H., Kwak, M. S., Shin, J. M., Hayuningtyas, R. A., Choi, J., & Shin, J. (2018) · Journal of Cell Science · doi:10.1242/jcs.211201 · Cited by 23
Zhang, X., Cai, L., Zhao, S., Long, J., Li, J., Wu, L., Su, J., Jiangling, Z., Tao, J., Zhou, J., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.06.014 · Cited by 21
Xie, W., & Xu, L. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112385 · Cited by 21
Why cancer incidence in the Arab counties is much lower than other parts of the world?
Arafa, M. A., & Farhat, K. H. (2022) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-022-00142-3 · Cited by 21
Drugging cancer metabolism: Expectations vs. reality
Montrose, D. C., & Galluzzi, L. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.07.007 · Cited by 21
Self-citationMicroRNAs in Rectal Cancer: Functional Significance and Promising Therapeutic Value
Imedio, L., Cristóbal, I., Rubio, J., Santos, A., Rojo, F., & García‐Foncillas, J. (2020) · Cancers · doi:10.3390/cancers12082040 · Cited by 21
Zhao, L., Chen, H., Zhang, Q., Ma, J., Hu, H., & Xu, L. (2022) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-021-04393-0 · Cited by 20
Autophagy in fibroblasts induced by cigarette smoke extract promotes invasion in lung cancer cells
Hou, H., Pan, H., Liao, W., Lee, C., & Yu, C. (2020) · International Journal of Cancer · doi:10.1002/ijc.33127 · Cited by 20
Development of a specific live-cell assay for native autophagic flux
Safren, N., Tank, E. M. H., Malik, A. M., Chua, J. P., Santoro, N., & Barmada, S. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101003 · Cited by 18
Duan, Y., Wang, J., Wang, J., Yang, Q., Zhang, Q., Lu, S., Zhao, S., Chen, C., Sun, Y., Deng, J., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.136795 · Cited by 19
Buono, R., Tucci, J., Cutri, R. M., Guidi, N., Mangul, S., Raucci, F., Pellegrini, M. A., Mittelman, S. D., & Longo, V. D. (2023) · Cancers · doi:10.3390/cancers15245870 · Cited by 19
Benzodiazepines compromise the outcome of cancer immunotherapy
Montégut, L., Derosa, L., Messaoudene, M., Chen, H., Lambertucci, F., Routy, B., Zitvogel, L., Martins, I., & Kroemer, G. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2413719 · Cited by 18
Self-citationSchnöller, L. E., Piehlmaier, D., Weber, P., Brix, N., Fleischmann, D. F., Nieto, A. E., Selmansberger, M., Heider, T., Heß, J., Niyazi, M., et al. (2023) · Radiation Oncology · doi:10.1186/s13014-023-02241-4 · Cited by 19
Lysosome-targeting agents in cancer therapy
Kroemer, G., & Galluzzi, L. (2017) · Oncotarget · doi:10.18632/oncotarget.21451 · Cited by 17
Self-citationWang, D.-H., He, X. J., & He, Q. (2019) · Bioscience Reports · doi:10.1042/bsr20190459 · Cited by 16
Huang, Y., You, X., Wang, L., Zhang, G., Gui, S., Jin, Y., Zhao, R., & Zhang, D. (2020) · Angewandte Chemie · doi:10.1002/ange.202001906 · Cited by 17
Advance in circular RNA modulation effects of heart failure
Jiang, L., Wang, X., Zhan, X., Kang, S., Liu, H., Luo, Y., & Lin, L. (2020) · Gene · doi:10.1016/j.gene.2020.100036 · Cited by 17
Woods, K. E., Neph, R., Nguyen, D. T. D., & Sheng, K. (2019) · Medical Physics · doi:10.1002/mp.13870 · Cited by 20
Stratifying nutritional restriction in cancer therapy: Next stop, personalized medicine
Krstić, J., Pieber, T. R., & Prokesch, A. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.03.001 · Cited by 18
Guaiazulene Triggers ROS-Induced Apoptosis and Protective Autophagy in Non-small Cell Lung Cancer
Ye, Q., Zhou, L., Jin, P., Li, L., Zheng, S., Huang, Z., Liu, J., Qin, S., Liu, H., Zou, B., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.621181 · Cited by 17
Seliger, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02043 · Cited by 17
Zhou, Y., & Shao, C. (2020) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2020.108362 · Cited by 14
Modulating autophagy to treat diseases: A revisited review on in silico methods
Wu, L., Jin, W., Yu, H., & Liu, B. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.05.002 · Cited by 16
Chang, L., Huang, Z., Li, S., Yao, Z., Bao, H., Wang, Z., Li, X., Chen, X., Huang, J., & Zhang, G. (2019) · Europe PMC (PubMed Central) · Cited by 15
Bi, W., Bi, Y., Li, P., Hou, S., Yan, X., Hensley, C., Bammert, C. E., Zhang, Y., Gibson, K. M., Ju, J., et al. (2018) · ACS Omega · doi:10.1021/acsomega.8b02139 · Cited by 15
Yang, H., Lin, R., Karuppaiya, P., Mathew, D. C., Way, T., Lin, H., Lee, C.-C., & Hseu, Y. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27749 · Cited by 15
Engineered oncolytic bacteria for malignant solid tumor treatment
Wang, M., Song, X., Liu, X., Ma, C., Ma, J., & Shi, L. (2024) · Interdisciplinary medicine · doi:10.1002/inmd.20240005 · Cited by 16
Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors
Kroemer, G., & Galluzzi, L. (2016) · Oncotarget · doi:10.18632/oncotarget.13892 · Cited by 15
Self-citationHeme Induces BECN1/ATG5-Mediated Autophagic Cell Death via ER Stress in Neurons
Yang, Z., Zhou, C., Shi, H. R., Zhang, N., Tang, B., & Ji, N. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00275-0 · Cited by 14
Metadata
- Authors
- Galluzzi, L., Bravo-San Pedro, J. M., Demaria, S., Formenti, S. C., & Kroemer, G.
- Affiliations
- Inserm (FR)
- Weill Cornell Medicine (US)
- Karolinska University Hospital (SE)
- Corresponding author
- Galluzzi, Lorenzo
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2016-11-15
- Volume
- 14
- Issue
- 4
- Pages
- 247-258
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W2549172728
- Cited by
- 314
- References
- 126
- Citations by year
- 2026: 14 · 2025: 13 · 2024: 22 · 2023: 36 · 2022: 36 · 2021: 30 · 2020: 43 · 2019: 45 · 2018: 43 · 2017: 30 · 2016: 1
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA198533, R01CA161891, R01CA201246)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- autophagy, autophagy activation, immunogenic chemotherapy, radiotherapy, cancer immunotherapy, antitumor immunity, autophagy inhibition, tumor microenvironment, tumor immunosuppression
- MeSH terms
- Autophagy, Clinical Trials as Topic, Forecasting, Humans, Immunotherapy, Neoplasms, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review